French health reform bill to address drug shortages, clinical trials
This article was originally published in SRA
Executive Summary
The French parliament is preparing to examine a bill reforming the healthcare system as part of the national health strategy launched by the government in 20131. While the main thrust of the draft "Health Law" is to iron out inequalities and inefficiencies in the healthcare system, it includes proposals to avoid shortages of high therapeutic value medicines and to bring French legislation into line with the new EU Clinical Trials Regulation.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.